Affistash vs Ampliz: Different Tools, Different Jobs
If you're comparing Affistash and Ampliz, your research took a wrong turn somewhere. These tools don't compete. Affistash is affiliate partner discovery software - it helps brands find and recruit affiliates, publishers, and influencers. Ampliz is a B2B sales intelligence platform focused on APAC and healthcare contact data. On G2, Affistash sits in the Affiliate Marketing Software category while Ampliz sits in Sales Intelligence, alongside tools like ZoomInfo, Seamless.AI, Apollo.io, UpLead, Lead411, and Lusha.
We've seen this comparison pop up before. It's a category mismatch every time. Here's what each tool actually does, who should use which, and what to grab if you need B2B contact data for outbound sales.
30-Second Verdict
- Need to recruit affiliates and partners? Affistash. It scours the web for publishers, bloggers, and influencers, then gives you a CRM to manage outreach.
- Need B2B contact data in APAC or healthcare? Ampliz. It covers 400M+ contacts across 16 APAC countries with a deep healthcare directory of 4M+ physicians and 9,000+ hospitals.
- Need accurate B2B emails and mobiles for general sales prospecting? Skip both. Prospeo covers 300M+ profiles with 98% email accuracy, 125M+ verified mobiles, and a 7-day refresh cycle. The free tier gives you 75 verified emails per month, no card required.
Side-by-Side Comparison
| Affistash | Ampliz | Prospeo | |
|---|---|---|---|
| Category | Affiliate discovery | Sales intelligence | B2B data platform |
| Use case | Find & recruit partners | APAC/healthcare leads | Verified emails & mobiles |
| Database size | N/A (partner discovery) | 400M+ contacts | 300M+ profiles |
| Starting price | $97/mo (20% off annual) | $50/mo | Free; paid from ~$39/mo |
| Free tier | 3-day trial; 30-day guarantee | 10 credits/mo | 75 emails/mo |
| Target user | Affiliate managers | Sales/marketing (APAC) | SDRs, RevOps, agencies |


Affistash finds affiliates. Ampliz covers APAC. Neither solves global B2B prospecting. Prospeo gives you 300M+ profiles, 143M+ verified emails at 98% accuracy, and 125M+ mobile numbers - all refreshed every 7 days, not every 6 weeks.
Start with 75 free verified emails - no credit card, no sales call.
What Each Tool Actually Does
Affistash
Affistash launched in 2023 and targets SMB brands running affiliate programs. Its founder shared early traction data on Reddit - the tool is young and still building out its feature set. It searches the web to find partners ranking for relevant keywords, then surfaces contact details and audience analytics so you can prioritize who to recruit first.

Strengths: Easy to use, AI-powered email sequences for affiliate recruitment. G2 reviewers praise the simplicity but want deeper analytics.
Weaknesses: Limited automation and team collaboration features. At $97/mo with an annual discount and no ongoing free plan - just a 3-day free trial plus a 30-day money-back guarantee - it's a real commitment for smaller programs. If you're running a side-project affiliate program with a handful of partners, that price stings.
Ampliz
Ampliz is Asia Pacific's largest B2B data platform, with 400M+ contacts across 16 countries. Its healthcare directory is the standout: 4M+ physicians, 9,000+ hospitals, 200K+ clinics. The Global B2B plan starts at $50/mo with 100 credits, and a free tier offers 10 credits.
Strengths: Strong APAC coverage, verified emails and direct dials, GDPR compliance support. Filtering by industry, company size, and tech stack works well for targeted prospecting in the region.
Weaknesses: The UI feels dated. One G2 reviewer noted the export workflow takes more clicks than it should, which adds up fast when you're pulling lists daily. Data completeness drops for smaller companies and non-APAC regions - if you're prospecting in North America or Europe, you'll notice the gaps quickly.
Better Options for B2B Contact Data
Let's be honest: if your prospecting isn't limited to APAC healthcare, neither of these tools belongs in your stack. Affistash doesn't do B2B contact data at all. Ampliz does, but its coverage thins out fast outside its core markets.

We've tested dozens of data platforms over the years, and data freshness is the single biggest factor most teams underestimate. Stale data kills deliverability, tanks your sender reputation, and wastes hours of SDR time on bounced emails and disconnected numbers. Prospeo's 7-day data refresh cycle addresses this directly - the industry average sits around six weeks, which means most platforms are serving you contacts that changed jobs a month ago.
The numbers back it up: 300M+ profiles globally, 143M+ verified emails at 98% accuracy, and 125M+ verified mobile numbers with a 30% pickup rate. Pricing runs about $0.01 per lead. Teams using Prospeo book 26% more meetings compared to ZoomInfo and 35% more compared to Apollo, largely because fresher data means fewer bounces and more live connections.
If you’re building lists at scale, it’s also worth comparing email finding tools and running a proper email address verification step before sending.


Stale data outside APAC is Ampliz's blind spot. Prospeo refreshes all 300M+ records every 7 days and delivers a 30% mobile pickup rate globally. At $0.01 per lead, teams book 26% more meetings than with ZoomInfo.
Stop paying enterprise prices for outdated contacts.
FAQ
Does Ampliz have a free plan?
Yes - 10 credits per month, no credit card required. It's enough to test data quality in your target APAC or healthcare market before committing to the $50/mo paid plan.
Can Affistash find B2B contact data?
No. Affistash finds affiliate partners - publishers, bloggers, influencers - and manages recruitment outreach. For verified B2B emails and phone numbers, you need a dedicated data platform.
Is Ampliz good for prospecting outside APAC?
Ampliz claims 400M+ contacts globally, but data completeness drops noticeably for smaller companies and non-APAC regions. For broader geographic coverage with weekly data refreshes, a platform with a 7-day refresh cycle and 300M+ global profiles will deliver more consistent results worldwide.
